Article Listing - Alios BioPharma licenses two nucleotide drug candidates to Vertex for up to $1.5 billion

9 March 1992

The Council of Ministers of the Commission of the European Community has adopted, as expected, a common position on the...

9 March 1992

As far as cold remedies in European markets are concerned, 1991 was a year of mixed fortunes. In some, the...

9 March 1992

The government of France appears at last to be prepared to endorse a new agreement on medical fees and drug...

9 March 1992

US pharmaceutical concern Pfizer has acquired all outstanding shares of Koshin Medical KK, a medical equipment wholesaler in Japan,...

9 March 1992

Among Management Forum's meetings to be held in London in March are Over-The-Counter Medicines (Conf No E3-17), March 24 and...

9 March 1992

Hans Ruediger Vogel, the director of the German drug industry association, the BPI, has warned against excessive expectations from the...

9 March 1992

Following recent reports that HMG-CoA reductase inhibitor products may have serious side effects, a spokeswoman for Merck has told the...

9 March 1992

A research project carried out by scientists from Athena Neurosci-ences in collaboration with Stanford University of California, USA, and the...

9 March 1992

At Marion Merrell Dow: Linda Hogan becomes director of licensing; Kevin Hartley named director of taxes; Jill Goodman to...

9 March 1992

George Poste, chairman of R&D at SmithKline Beecham Pharmaceuticals, has been elected an executive director of Smith-Kline Beecham plc.

Showing 94711-94720 of 95353 articles